CHINESE BIOPHARMACEUTICAL ASSOCIAT… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2001

Legal Domicile

Phone

2408882704

Tax Period

2025-01-01 to 2025-12-31

CHINESE BIOPHARMACEUTICAL ASSOCIATION USA, founded in 2001, is a small nonprofit in the Medical Research sector that reported $130K in total revenue in fiscal year 2025. Revenue decreased 8% compared to the prior year. Expenses of $121K left a modest 7% surplus.

Mission

HOLD CONFERENCES, MEETINGS, WORKSHOPS, AND ACTIVITIES TO FACILITATE COLLABORATION AMONG SCIENTISTS, ENGINEERS AND OTHER RELATED PROFESSIONALS IN BIOPHARMACEUTICAL FIELD

Program Service Accomplishments

Program 1

Expenses: $111,557

HOLD CONFERENCES, MEETINGS, WORKSHOPS, AND ACTIVITIES TO FACILITATE COLLABORATION AMONG SCIENTISTS, ENGINEERS AND OTHER RETLATED PROFESSIONALS IN BIOPHARMACEUTICAL FIELD.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $129,545

Program Service Revenue $0

Investment Income $33

Other Revenue $0

TOTAL REVENUE $129,578

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $111,557

Other Expenses $121,100

TOTAL EXPENSES $121,100

Year-over-Year Comparison

	2025	2024	Change
Revenue	$129,578	$141,292	-0.1%
Expenses	$121,100	$146,293	-0.2%
Net Income	$8,478	$-5,001	-2.7%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Edward Wang	Director	1.00	Director	$0	$0	$0
Ping Chen	Director	1.00	Director	$0	$0	$0
Richard Zhao	Director	1.00	Director	$0	$0	$0
Shoupeng Lai	Director	1.00	Director	$0	$0	$0
Xiaobin Lu	Director	1.00	Director	$0	$0	$0
Xu-Rong Jiang	Director	1.00	Director	$0	$0	$0
Yali Fu	Director	1.00	Director	$0	$0	$0
Helen Mao	Director	1.00	Director	$0	$0	$0
Yingxian Xiao	Director	1.00	Director	$0	$0	$0
Zhifeng Long	Director	1.00	Director	$0	$0	$0
Ziping Wei	Director	1.00	Director	$0	$0	$0
Shou-Bai Chao	Director	1.00	Director	$0	$0	$0
Qiao Yu	Director	1.00	Director	$0	$0	$0
Alex Lai	Director	1.00	Director	$0	$0	$0
Hao Li	Director	1.00	Director	$0	$0	$0
Qi Zeng	Director	1.00	Director	$0	$0	$0
Angela Men	Director	1.00	Director	$0	$0	$0
Monica Zhang	Director	1.00	Director	$0	$0	$0
You Li	Director	1.00	Director	$0	$0	$0
Steve Chen	Director	1.00	Director	$0	$0	$0
Li Li	Director	1.00	Director	$0	$0	$0
Chuanhua Xing	Director	1.00	Director	$0	$0	$0
Jingyu Luan	Director	1.00	Director	$0	$0	$0
Yuling Wu	Director	1.00	Director	$0	$0	$0
Hang Lu	Director	1.00	Director	$0	$0	$0
Song Wu	Director	1.00	Director	$0	$0	$0
Dong Shen	Director	1.00	Director	$0	$0	$0
Harry Yang	Director	1.00	Director	$0	$0	$0
Qing Li	Director	1.00	Director	$0	$0	$0
FEIYAN JIN	Treasurer	0.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$129,578	$121,100	$684,982	$8,478
2024	No data	No data	No data	No data
2023	$123,294	$141,241	$681,505	$-17,947
2022	$68,050	$82,255	$699,452	$-14,205
2021	$140,026	$31,264	$713,657	$108,762
2020	$40,416	$62,410	$604,895	$-21,994
2019	$590,604	$212,362	$626,889	$378,242

CHINESE BIOPHARMACEUTICAL ASSOCIATION USA